Regulatory approvals for Lumakras The European Commission approved Lumakras in January 2022, following the receipt of a recommendation for conditional marketing authorisation from the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) in November 2021. The Japan Min...